Sarepta Therapeutics: Q4 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Tuesday reported a loss of $109.2 million in its fourth quarter...
March 1, 2023
2:22 AM
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Tuesday reported a loss of $109.2 million in its fourth quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.24. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.28 per share. The biopharmaceutical company posted revenue of $258.4 million in the period, also topping Street forecasts.